-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2023.
- Orchard Therapeutics plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$35.3M, a 25.7% increase year-over-year.
- Orchard Therapeutics plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$72.9M, a 59.3% increase year-over-year.
- Orchard Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2022 was -$151M, a 4.2% decline from 2021.
- Orchard Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2021 was -$145M, a 4.87% increase from 2020.
- Orchard Therapeutics plc annual Net Income (Loss) Attributable to Parent for 2020 was -$152M, a 7% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)